Influence of skeletal site of origin and donor age on 1,25(OH)2D3-induced response of various osteoblastic markers in human osteoblastic cells

Bone

Volumn 24, Issue 3, 1999, Pages 203-209

  Martinez M E ^a   Medina, S ^a   Sanchez M ^a   Del Campo, M T ^a   Esbrit, P ^b   Rodrigo, A ^a   Martinez P ^a   Sanchez Cabezudo M J ^a   Moreno, I ^a   Garces M V ^a   Munuera, L ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

1,25(OH)2D3; Aging; Osteoblasts; Primary culture; Skeletal site

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; MARKER; OSTEOCALCIN; PROCOLLAGEN; PROCOLLAGEN C PROTEINASE;

ADULT; AGED; AGING; ARTHROPLASTY; ARTICLE; CELL CULTURE; CELL SECRETION; CONTROLLED STUDY; DONOR; FEMALE; HIP; HUMAN; HUMAN CELL; HUMAN TISSUE; KNEE; MAJOR CLINICAL STUDY; MALE; OSTEOBLAST; TRABECULAR BONE;

EID: 0033105037     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(98)00181-1     Document Type: Article

References (45)

1. 3. Endocrinology. 133:1993;553-562.
2. 3, parathyroid hormone and glucorticoids. Metab Bone Dis Rel Res. 5:1984;229-234.
3. 3 and human bone derived cells in vitro. Effects on alkaline phosphatase, type I collagen and proliferation. Endocrinology. 119:1986;1776-1785.
4. Bonjour J.P., Theintz G., Buchs B., Slosman D., Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab. 73:1991;555-563.
5. Boonen S., Aerssens J., Dequeker J., Nicholson P., Cheng X., Lowet G., Verbeker G., Bouillon R. Age-associated decline in human femoral neck cortical and trabecular content of insulin-like growth factor I Potential implications for age-related (type II) osteoporotic fracture occurrence . Calcif Tissue Int. 61:1997;173-178.
6. Chavassieux P.M., Chenu C., Valentin-Opran A., Merle B., Delmas P.D., Hartmann D.J., Saez S., Meunier P.J. Influence of experimental conditions on osteoblast activity in human primary bone cell cultures. J Bone Miner Res. 5:1990;337-343.
7. 3 and dexamethasone on rat osteoblast-like primary cell cultures. Receptor occupancy and functional expression patterns for three different bioresponses. Endocrinology. 118:1986;250-259.
8. Davis J.W., Ross P.D., Wasnich R.D. Evidence for both generalized and regional low bone mass among elderly women. J Bone Miner Res. 9:1994;305-309.
9. Dawson-Hughes B., Dallal G.E., Krall E.A., Harris S., Sokoll L.J., Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med. 115:1991;505-512.
10. Dempster D.W. Bone remodeling. Coe F.L., Favus M.J., Disorders of Bone and Mineral Metabolism. 1992;355-380 Raven, New York.
11. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., Smith E., Bonadio J., Goldstein S., Gundberg C., Bradley A., Karsenty G. Increased bone formation in osteocalcin-deficient mice. Nature. 382:1996;448-452.
12. Evans C.E., Charles S.B., Galasko B., Ward C. Effect of donor age on the growth in vitro of cells obtained from human trabecular bone. J Orthop Res. 8:1990;234-237.
13. 3 on the cytoskeleton of rat calvaria and rat osteosarcoma (ROS 17/2.8) osteoblastic cells. J Bone Miner Res. 1:1986;441-455.
14. Heersche J., Reimers S., Denkovski P., Bellows C., Aubin J. Heterogeneity of osteoblasts in vivo and in vitro. Christiansen C., Riis B., Proceedings 4th International Symposium on Osteoporosis. 1993;225-227 Osteopress, Rodovre, Denmark.
15. Hock J.M., Onyia J., Bidwell J. Comparisons of in vivo and in vitro models of the response of osteoblasts to hormonal regulation with aging. Calcif Tissue Int. 56:(Suppl.):1995;S44-S47.
16. 3-induced effect on human osteoblast-like MG-63 cells. J Bone Miner Res. 10:1995;1050-1056.
17. Kasperk C., Wergedal J., Strong D., Farley J., Wangerin K., Gropp H., Ziegler R., Baylink D.J. Human bone cell phenotypes differ depending on their skeletal site of origin. J Clin Endocrinol Metab. 80:1995;2511-2517.
18. Kassem M., Blum W., Risteli J., Mosekilde L., Eriksen E.F. Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int. 52:1993;222-226.
19. Lian J.B., Tassinari M., Glowack J. Resorption of implanted bone prepared from normal and warfarin-treated rats. J Clin Invest. 73:1984;1223-1226.
20. 3 receptor-like macromolecule in rat osteogenic sarcoma cell lines. J Biol Chem. 255:1980;4414-4417.
21. Marie P.J. Human endosteal osteoblastic cells Relationship with bone formation . Calcif Tissue Int. 56:(Suppl.):1995;S13-S16.
22. Marie P.J., Sabbagh A., De Vernejoul M.C., Lomri A. Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis. J Clin Endocrinol Metab. 69:1989;272-279.
23. Martínez M.E., Del Campo M.T., Sánchez M., Medina S., Sánchez-Cabezudo M.J., Moreno I., Munuera L. Influence of skeletal site of origin on human osteoblastic cell proliferation and function in vitro. J Bone Miner Res. 12:(Suppl.):1997;S188.
24. Martínez M.E., García-Ocaña A., Sánchez M., Medina S., Del Campo T., Valin A., Sánchez-Cabezudo M.J., Esbrit P. C-terminal parathyroid hormone-related protein inhibits proliferation and differentiation of human osteoblast-like cells. J Bone Miner Res. 12:1997;778-785.
25. Martínez M.E., Medina S., Del Campo M.T., Sánchez-Cabezudo M.J., Sánchez M., Munuera L. Effect of polyethylene on osteocalcin, alkaline phosphatase and procollagen secretion by human osteoblastic cells. Calcif Tissue Int. 62:1998;453-456.
26. Ooms M.E., Ross J.C., Bezemer D., Van der Vijgh W.J.F., Bouler L.M., Lips P. Prevention of bone loss by vitamin D supplementation in elderly women A randomized double-blind trial . J Clin Endocrinol Metab. 80:1995;1052-1058.
27. Owen T.A., Aronow M.S., Barone L.M., Bettencourt B., Stein G.S., Lian J.B. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype Dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures . Endocrinology. 128:1991;1496-1504.
28. Parfitt A.M. The physiological and clinical significance of bone histomorphometric data. Recker R.R., Bone histomorphometric data Techniques and interpretation . 1983;143-223 CRC, Boca Raton, FL.
29. Pfeilschifter J., Diel I., Pilz U., Brunotte K., Naumann A., Ziegler R. Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age. J Bone Miner Res. 8:1993;707-717.
30. Podenphant J., Engel U. Regional variations in histomorphometric bone dynamics from the skeleton of an osteoporotic woman. Calcif Tissue Int. 40:1987;184-188.
31. Price P.A. Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. Proc Natl Acad Sci USA. 79:1982;7734-7738.
32. Prockop, D. J., Kivirikko, K. I., Tuderman, L., and Guzman, N. A. The biosynthesis of collagen and its disorders. N Engl J Med 301:13-23, 77-85; 1979.
33. Rawlinson S.C.F., Mosley J.R., Suswillo R.F.L., Pitsillides A.A., Lanyon L.E. Calvarian and limb bone cells in organ and monolayer culture do not show the same early responses to dynamic mechanical strain. J Bone Miner Res. 10:1995;1225-1232.
34. Roholl P.J.M., Blauw E., Zurcher C., Dormans J.A.M.A., Theuns H.M. Evidence for a diminished maturation of preosteoblasts into osteoblasts during aging in rats An ultrastructural analysis . J Bone Miner Res. 9:1994;355-366.
35. Sabokbar A., Millett P.J., Myer B., Rushton N. A rapid quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro. Bone Miner. 27:1994;57-67.
36. Sherman S., Gehron Robey P., Hadley E.C. Aging and the human skeleton Recommendations for research . Calcif Tissue Int. 56:(Suppl.):1995;S3-S4.
37. Shigeno Y., Ashton B.A. Human bone-cell proliferation in vitro decreases with human donor age. J Bone Jt Surg. 77:1995;139-142.
38. Skjodt H., Gallagher J.A., Beresford J.N., Couch M., Poser J.W., Russell G.G. Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro. J Endocrinol. 105:1985;391-396.
39. 3) on alkaline phosphatase and GLA protein of rat osteoblastic cells. Endocrinology. 118:1986;1340-1346.
40. Stein G.S., Lian J.B., Stein J.L., Van Wijnen A.J., Mortecino M. Transcriptional control of osteoblast growth and differentiation. Physiol Rev. 2:1996;593-622.
41. 3-mediated transforming growth factor β release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies. J Bone Miner Res. 11:1996;367-376.
42. Stern P.H. Vitamin D and bone. Kidney Int. 38:(Suppl.):1990;S17-S21.
43. Vanderschueren D., Gevers G., Raymaekers G., Devos P., Dequeker J. Sex- and age-related changes in bone and serum osteocalcin. Calcif Tissue Int. 46:1990;179-182.
44. 3. Metabolism. 41:1992;42-48.
45. Wong M.M., Rao L.G., Ly H., Hamilton L., Ish-Shalom S., Sturtridge W., Tong J., McBroom R., Josse R.G., Murray T.M. In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls. Osteopor Int. 4:1994;21-31.